Inpatient Drug Rehab Houston (855) YES REHAB – The Addiction Hotline was created to help Parents, Teens, Husbands and Wives, Friends or Family get help anytime day or night with one easy to use phone numb…
Analysis Demonstrates Cost-Effectiveness Of Managing Low-Density …
Filed under:Drug Treatment Help Sacramento
This simple blood test was cleared by the U.S. Food and Drug Administration (FDA) in July 2008, and can help clinicians individualize the management of patients with established cardiovascular risk, which may lead to fewer cardiovascular events and … Read more on Sacramento Bee
Royalty Pharma lets Elan takeover bid expire
Filed under:Drug Treatment Help Sacramento
In April, Elan sold its interest in the multiple sclerosis treatment Tysabri to former development partner Biogen Idec Inc. That deal was worth $ 3.25 billion in cash and recurring royalty payments. The drugmaker also attempted to diversify its business … Read more on Sacramento Bee
Synthetic Biologics to Present at OneMedForum New York 2013
Filed under:Drug Treatment Help Sacramento
In addition, the Company is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis. … Reader comments on Sacbee.com are the opinions of the writer, not The Sacramento Bee. Read more on Sacramento Bee
Inpatient Drug Rehab Houston (855) YES REHAB
Inpatient Drug Rehab Houston (855) YES REHAB – The Addiction Hotline was created to help Parents, Teens, Husbands and Wives, Friends or Family get help anytime day or night with one easy to use phone numb…
Analysis Demonstrates Cost-Effectiveness Of Managing Low-Density …
Filed under: Drug Treatment Help Sacramento
This simple blood test was cleared by the U.S. Food and Drug Administration (FDA) in July 2008, and can help clinicians individualize the management of patients with established cardiovascular risk, which may lead to fewer cardiovascular events and …
Read more on Sacramento Bee
Royalty Pharma lets Elan takeover bid expire
Filed under: Drug Treatment Help Sacramento
In April, Elan sold its interest in the multiple sclerosis treatment Tysabri to former development partner Biogen Idec Inc. That deal was worth $ 3.25 billion in cash and recurring royalty payments. The drugmaker also attempted to diversify its business …
Read more on Sacramento Bee
Synthetic Biologics to Present at OneMedForum New York 2013
Filed under: Drug Treatment Help Sacramento
In addition, the Company is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis. … Reader comments on Sacbee.com are the opinions of the writer, not The Sacramento Bee.
Read more on Sacramento Bee